R
egenerating the adult human heart remains a central barrier in cardiovascular medicine. Developing effective cardiac regenerative therapies has proven to be challenging because of a lack of mechanistic understanding of the key processes required for endogenous heart regeneration. Peering into natural mechanisms of heart regeneration in animal models is beginning to provide a blueprint for regeneration, which could be exploited therapeutically in humans.
Efficient and complete regeneration after cardiac injury in adult vertebrates has been demonstrated in newts, zebrafish, and axolotls (Figure, A). 1 Although it was previously believed that mammals had lost their capacity for heart regeneration during evolution, recent studies have shown that neonatal mice are able to mount a robust regenerative response after injury (Figure, A) . 2 However, this regenerative potential in neonatal mice rapidly diminishes after birth. 2 It is important to note that the evolutionary conservation of the cardiac regenerative program in the neonatal mouse heart has raised the exciting prospect that this dormant regenerative program could be reactivated in adulthood if the underlying mechanisms could be unraveled. However, it was unclear whether large mammals, including humans, shared a similar developmental window for heart regeneration.
In this issue of Circulation, studies by Ye et al 3 and Zhu et al 4 demonstrate that similar to neonatal mice, 1-day-old (P1) and 2-day-old (P2) neonatal pigs are capable of mounting a cardiac regenerative response after myocardial infarction (MI) characterized by restoration of contractile function, cardiomyocyte replenishment, and minimal fibrosis. It is interesting to note that this regenerative capacity is rapidly lost after the first 2 days of life. This brief window of regeneration has also been documented recently in the neonatal mouse heart. 5 Similar to regeneration in neonatal mice, the proliferation of preexisting cardiomyocytes appears to be the primary source of cardiomyocyte replenishment in neonatal pigs, with markers of cardiomyocyte mitosis, sarcomere disassembly, and cytokinesis elevated after injury in the P1 and P2 hearts but not at later time points. BrdU pulse-chase experiments further demonstrated that cardiomyocyte DNA synthesis was increased after neonatal pig MI as well. 3 Cardiomyocyte proliferation significantly decreased after this 2-day window, which was associated with a marked reduction in telomerase activity. 4 Thus, in mice and pigs, cardiac regenerative capacity appears to be driven by cardiomyocyte proliferation and sharply declines after the first 2 days of postnatal development.
The timing of regenerative arrest in mice and pigs is intriguing given substantive differences in the rates of cardiomyocyte cell cycle withdrawal and binucleation in both species. In rodents, cardiomyocytes exit the cell cycle shortly after birth with the cessation of cytokinesis and persistence of karyokinesis resulting in binucle-ation of ≈90% of cardiomyocytes by the second week of postnatal life. 6 In contrast, in pigs, ≈10% of cardiomyocytes are binucleated at birth, which increases to ≈30% in adulthood. 7 In most mammals, diploid cardiomyocyte nuclei predominate (>90% in mice, rats, rabbits, sheep, horses, and oxen). 8 However, higher ploidy levels are found in pig and human hearts, which also comprise tetraploid, 6c, 8c, and 12c nuclei. 8 Moreover, both pig and human cardiomyocytes undergo polyploidy after the neonatal period. 8 The mechanisms that drive polyploidy versus binucleation of cardiomyocytes in different species remain unclear. Nevertheless, pigs may be a better model than other mammalian species to study developmental mechanisms regulating cardiomyocyte proliferation and cardiac regeneration in humans. Furthermore, the 2 recent neonatal pig studies published in this issue, 3, 4 along with recent findings in neonatal mice, 5 suggest that loss of cardiac regenerative capacity during postnatal development may be uncoupled from the cardiomyocyte binucleation process. Although mononucleated, proliferation-competent cardiomyocytes likely represent a permissive requirement for neonatal heart regeneration, cell cycle withdrawal and binucleation may not be the sole drivers of regenerative arrest after birth. Thus, what other mechanisms could account for the sudden decline in cardiac regenerative capacity after birth in mammals?
It is well known that inductive and instructive cues from nonmyocyte populations play an important role in the initiation and coordination of the neonatal cardiac regenerative program (Figure, B) . For example, the immune system undergoes profound adaptation during the switch from the in utero to postnatal environment. Macrophages play an essential role in the initiation of the neonatal cardiac regenerative response by releasing cytokines that drive both cardiomyocyte proliferation and angiogenesis after injury. 9, 10 Similarly, recent studies suggest that the extracellular matrix plays a key role in instructing the cardiac regenerative response by providing a permissive biomechanical environment and growth factors that can facilitate cardiomyocyte proliferation. 5, 11 Extracellular matrix composition and stiffness change rapidly within 1 to 2 days after birth, which could partially account for the sudden decline in cardiac regenerative potential in the neonatal period. 5 Recent studies have also highlighted the important role of autonomic neural input in neonatal heart regeneration, whereby cholinergic signaling governs the local inflammatory response and cardiomyocyte proliferation after injury. 12 Finally, cardiac regenerative potential has recently been linked with rapid changes in atmospheric oxygen concentrations and subsequent alterations in metabolism that occur after birth in mammals. 13 The developmental loss of cardiac regenerative capacity after birth in mammals most likely results from a combination of these complex physiological adaptations, which allow the cardiovascular system to cope with the increased demands of life outside the womb. 1 To further elucidate the mechanisms driving cardiac regeneration in neonatal pigs, Ye et al 3 performed RNAseq analysis. Regenerating hearts were characterized by limited expression of a fibrotic gene profile after MI, which was in stark contrast to the nonregenerating older hearts. It is interesting to note that a few differentially expressed genes were detected after cardiac injury in the regenerating neonatal hearts. These results are in line with a recent comprehensive transcriptional profiling of the regenerating neonatal mouse heart.
14 Therefore, transcriptional profiling of the neonatal cardiac regenerative response in both small and large mammals indicates that the developmental regenerative gene program is already active at this early developmental stage, rather than being induced in response to injury. Dissecting the molecular mechanisms that initiate the cardiac regenerative response after injury and silence the neonatal regenerative program after birth will be important areas for future investigations.
Collectively, the studies by Ye et al 3 and Zhu et al 4 provide evidence that neonatal pigs, which have a similar developmental trajectory to humans, retain the ability to regenerate the heart for a short period after birth. These studies provide a critical translational bridge for current attempts to regenerate the adult human heart via reinduction of developmental programs. Moreover, these studies reveal the existence of a regenerative window of opportunity in the neonatal period in large mammals, which could potentially be exploited for therapeutic intervention in the context of surgical repair for congenital heart disease. Although more work is required to define the mechanisms underlying neonatal heart regeneration, including the lineage origins of regenerated cardiomyocytes in large mammals, recent advances in genome-editing techniques open up exciting avenues for future mechanistic interrogation using the pig as a model system. 15 The possibility of studying natural mechanisms of heart regeneration in a large animal model brings us 1 step closer to the therapeutic goal of rejuvenating the human heart for cardiac repair. 
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